Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 63 Breast Neoplasms 28 Neoplasms 5 Neoplasm Metastasis 3 Leiomyoma 3 Cardiovascular Diseases 3 Polycystic Ovary Syndrome 2 Neoplasms by Site 2 Endometrial Neoplasms 2 Breast Diseases 2 Advanced Breast Cancer 2 Stage II Prostate Adenocarcinoma 1 Sleep Wake Disorders 1 Skin Diseases 1 Sexual Dysfunctions, Psychological 1 Sarcopenia 1 Salivary Gland Neoplasms 1 Salivary Gland Adenoma, Pleomorphic 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatectomy 1 Prostate Cancer With ≤10 Bone Metastases 1 Prostate Cancer Metastatic Disease 1 Prostate Cancer Metastatic 1 Pelvic Pain 1 Ovarian Neoplasms 1 Osteoporosis 1 Oligometastatic Prostate Carcinoma 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Metastatic Neuroendocrine Prostate Cancer 1

Interventions

enzalutamide 7 Prednisone 7 cabazitaxel 6 Radiosurgery 6 Docetaxel 5 Androgen Antagonists 4 Abiraterone Acetate 4 XRP6258 2 Standard of Care 2 talazoparib 1 sipuleucel-T 1 rucaparib 1 pembrolizumab 1 olaparib 1 gallium 68 PSMA-11 1 fludrocortisone acetate 1 darolutamide 1 apalutamide 1 Zuclomiphene 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisolone 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Midazolam 1 Lutetium-177 1 Lutetium 1 Lenograstim 1 LY3023414 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Metastatic × Gonadotropin-Releasing Hormone × Clear all

NCT04983095 2026-02-17

METRO

Umeå University

Phase NA Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡